TK
Alpha Teknova, Inc.
TKNO · NASDAQ
$7.45 +0.68% (+$0.05)
1M +3.33%
Market Cap $399.4M
P/E Ratio -
Div. Yield -
ROE 24.94%
Piotroski F-Score Weak
3/9Valuation
10 /100
Expensive P/S 9.14x
P/B 6.38x
P/E N/A
Growth
12 /100
Declining Rev. growth 0.73%
Book val. growth 11.70%
EPS growth N/A
Profitability
13 /100
Weak Gross margin 33.94%
Net margin 38.37%
FCF margin 16.37%
Quality
6 /100
Poor ROIC 17.48%
ROE 24.94%
Asset turnover 0.46x
Debt
64 /100
Moderate Debt/Equity 0.44x
Current ratio 4.49x
Int. coverage -18.12x
Stability
83 /100
Stable Beta 0.73x
Rev. volatility 9.82%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TKNO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Stephen Gunstream
Employees
158
Headquarters
Hollister
Upcoming events
05 NOV
Earnings
Upcoming earnings report